BioNTech SE

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$120,042
$898,890
$1,518,900
$260,800
Gross Profit
-75,826
568,716
1,370,600
184,400
EBITDA
-548,676
-67,362
149,299
-348,300
EBIT
-671,971
-230,616
25,099
-399,300
Net Income
-540,646
-302,139
-28,700
-386,600
Net Change In Cash
120,042
898,890
1,518,900
260,800
Free Cash Flow
-485,657
237,666
811,136
700,035
Cash
9,949,765
7,672,133
10,092,900
10,269,500
Basic Shares
252,884
245,157
239,166
241,625

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,756,632
$2,751,100
$3,819,000
$17,310,600
Gross Profit
2,140,162
2,209,800
3,219,200
14,315,600
EBITDA
-256,174
-367,100
1,377,400
13,096,300
EBIT
-623,865
-665,100
1,194,000
12,973,000
Net Income
-1,091,261
-665,300
930,300
9,434,400
Net Change In Cash
2,756,632
2,751,100
3,819,000
17,310,600
Free Cash Flow
269,813
-244,600
4,665,900
13,214,100
Cash
7,672,133
9,761,900
11,663,700
13,875,100
Basic Shares
241,700
240,400
242,700
249,800

Earnings Calls

QuarterEPS
2026-03-31
-$1.95
2025-12-31
-$0.33
2025-09-30
-$0.12
2025-06-30
-$1.60